🇺🇸 FDA
Pipeline program

REGN1908-1909

R1908-1909-ALG-2102

Phase 3 small_molecule terminated

Quick answer

REGN1908-1909 for Allergic Rhinitis Due to Cat Allergy is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Allergic Rhinitis Due to Cat Allergy
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials